10,011
Total Claims
$1.3M
Drug Cost
1,052
Beneficiaries
$1,212
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
-21%
Cost per patient vs peers
$1,212 vs $1,524 avg
-11%
Brand preference vs peers
12.2% vs 13.7% avg
Brand vs Generic
88% generic
Brand: 1,221 claims · $1.1M
Generic: 8,790 claims · $217K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 659 | $672K |
| Rivaroxaban | 126 | $147K |
| Ticagrelor | 107 | $73K |
| Sacubitril/Valsartan | 46 | $70K |
| Evolocumab | 69 | $49K |
| Irbesartan | 535 | $21K |
| Clopidogrel Bisulfate | 908 | $17K |
| Sotalol Hcl | 445 | $16K |
| Atorvastatin Calcium | 864 | $14K |
| Isosorbide Mononitrate | 403 | $14K |
| Prasugrel Hcl | 79 | $13K |
| Alirocumab | 20 | $13K |
| Dofetilide | 98 | $13K |
| Rosuvastatin Calcium | 619 | $12K |
| Carvedilol | 640 | $8,443 |
Prescribing Profile
51
Unique Drugs
$889K
Patient Profile
76
Avg Age
46%
Female
1.55
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data